14-3-3 η Proteins as a Diagnostic Marker, Disease Activation Indicator, and Lymphoma Predictor in Patients with Primary Sjögren Syndrome
CONCLUSION: 14-3-3η proteins are potential candidates for diagnostic marker, marker of disease activity, and predictor of lymphoma in PSS patients.PMID:38310415 | PMC:PMC10862092 | DOI:10.34172/aim.2023.85 (Source: Archives of Iranian Medicine)
Source: Archives of Iranian Medicine - February 4, 2024 Category: Middle East Health Authors: Ahmet Kor Merve Yal çın Şükran Erten Y üksel Maraş Esra F ırat Oğuz İsmail Doğan Ebru Atalar Salih Ba şer Özcan Erel Source Type: research
14-3-3 η Proteins as a Diagnostic Marker, Disease Activation Indicator, and Lymphoma Predictor in Patients with Primary Sjögren Syndrome
CONCLUSION: 14-3-3η proteins are potential candidates for diagnostic marker, marker of disease activity, and predictor of lymphoma in PSS patients.PMID:38310415 | PMC:PMC10862092 | DOI:10.34172/aim.2023.85 (Source: Archives of Iranian Medicine)
Source: Archives of Iranian Medicine - February 4, 2024 Category: Middle East Health Authors: Ahmet Kor Merve Yal çın Şükran Erten Y üksel Maraş Esra F ırat Oğuz İsmail Doğan Ebru Atalar Salih Ba şer Özcan Erel Source Type: research
14-3-3 η Proteins as a Diagnostic Marker, Disease Activation Indicator, and Lymphoma Predictor in Patients with Primary Sjögren Syndrome
CONCLUSION: 14-3-3η proteins are potential candidates for diagnostic marker, marker of disease activity, and predictor of lymphoma in PSS patients.PMID:38310415 | PMC:PMC10862092 | DOI:10.34172/aim.2023.85 (Source: Archives of Iranian Medicine)
Source: Archives of Iranian Medicine - February 4, 2024 Category: Middle East Health Authors: Ahmet Kor Merve Yal çın Şükran Erten Y üksel Maraş Esra F ırat Oğuz İsmail Doğan Ebru Atalar Salih Ba şer Özcan Erel Source Type: research
Analysis of diagnostic excisional lymph node biopsy results: 12-year experience of a single center
Acta Clin Croat. 2023 Apr;62(1):58-64. doi: 10.20471/acc.2023.62.01.07.ABSTRACTLymph node biopsy is indicated in patients with suspected malignancy or lymphadenopathy due to unclarified reasons. Lymph node biopsy can be performed as fine needle aspiration biopsy, core biopsy, or excisional lymph node biopsy. In particular, the diagnosis of malignant lymphoma is considered insufficient for oncological treatment unless classified into subgroups. Core biopsy and excisional biopsy can be performed to diagnose lymphoma and classify it into subgroups. Core biopsy may also be limited in some cases for the diagnosis of lymphoma. T...
Source: Acta Clinica Croatica - February 2, 2024 Category: General Medicine Authors: Zulfu Bayhan Kayhan Ozdemir Emre Gonullu Ahmet Tarik Harmantepe Recayi Capoglu Emrah Akin Mehmet Aziret Fatih Altintoprak Source Type: research
